Recofast 750 IV/IM Injection
Cefuroxime Sodium 750 mg IV
Product Key Facts
Anti-infectives
Medications used to combat bacterial infections and inhibit the growth of bacteria.
Fighting Bacterial Infections
Fighting bacterial infections involves the use of antibiotics, which are medications designed to target and eliminate bacteria. The choice of antibiotic depends on the type of bacteria causing the infection. It's crucial to complete the full course of prescribed antibiotics, even if symptoms improve, to prevent antibiotic resistance.
Details at a Glance
| Product Code | : | 1171 |
| Pack Size | : | 1x1's |
| MRP | : | ৳ 89 |
Specifications
Recofast 750 mg, belonging to the anti-infectives therapeutic class, is an antibiotic formulated for intramuscular (IM) or intravenous (IV) administration. Each vial of Recofast 750 mg contains Cefuroxime Sodium USP equivalent to 750 mg of Cefuroxime. This antibiotic, a second-generation cephalosporin, is effective against a broad spectrum of bacteria. The medication is provided in a form that requires reconstitution, and for this, each package includes an ampoule containing 10 ml of water for injection. To ensure a safe and sterile administration, Recofast 750 mg is also supplied with a sterile disposable 10 ml syringe, an alcohol prep pad, and a strip bandage.
Recofast 750 mg (Cefuroxime 750 mg) is indicated for the treatment of various bacterial infections. This includes severe or life-threatening infections like pneumonia, urinary tract infections, skin infections, intra-abdominal infections, bone and joint infections, and meningitis. It is also used in preoperative prophylaxis for surgical infection prevention and is effective in treating infections in patients with limited treatment options due to antibiotic resistance.
The dosage of Recofast 750 mg varies depending on the type, severity, and site of infection, as well as the patient's age, weight, and kidney function. The medication is administered either intramuscularly or intravenously, depending on the clinical situation.
For preparation, the Cefuroxime powder in the vial is reconstituted with the provided 10 ml of sterile water for injection. The solution should be prepared using aseptic techniques, employing the alcohol prep pad for cleaning and the sterile syringe for administration. After reconstitution, the solution should be used within a specified period to maintain efficacy and reduce the risk of contamination.
Patients and healthcare providers should be instructed on the correct preparation and administration techniques. The strip bandage can be used for post-injection care. The complete course of the antibiotic should be administered as prescribed, even if symptoms improve, to ensure the effective treatment of the infection and to prevent the development of resistance. Dosage adjustments may be necessary for patients with impaired kidney function, and these should be made under the guidance of a healthcare provider.
